To help accelerate early detection of pancreatic cancer, the PRECEDE Foundation will host its inaugural Light the Way Gala on ...

Revolution Medicines is a hold, with a promising cancer drug and strong pipeline but upside limited by a high valuation.

Double double toil and trouble, something wickedly good is brewing in St. Andrews. This Saturday, October 25 the Witches of ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell ...

Recent advancements in medical technology suggest that simple blood tests could significantly enhance early cancer detection.

Preliminary response rates suggest cell therapy may extend beyond haematology, although durability metrics remain necessary to assess true clinical benefit.

Preliminary data from first three patients in Phase 2b imaging clinical trial of RAD 101 show uptake in brain metastases from solid tumors, confirming proof-of-concept with Phase 2 topline results ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing ...

From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing together global leaders in oncology and pharmaceutical innovation. Representing ...

Inc. Class H ( ($HK:2595) ) just unveiled an update. GenFleet Therapeutics has announced promising results from ...

More women are defying traditional beauty standards and finding empowerment by going without hair on their heads.